Rhythm Pharmaceuticals (RYTM) Key Ratios
$115.02
As on 13-Nov-2026 16:00EST
Market cap
$7,974 Mln
Revenue (TTM)
$281 Mln
P/E Ratio
--
P/B Ratio
86.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 29.29 | 79.59 | 61.04 | 65.45 | 191.36 |
| EBIT | 18.17 | 24.53 | -2.07 | -0.26 | -2.75 |
| Net Profit | 16.08 | 21.80 | -0.77 | -1.51 | -202.73 |
| EPS | 16.63 | 27.13 | 6.43 | 4.05 | -172.87 |
| Book Value | -- | -- | 51.14 | -4.90 | 1.40 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -165.49 | -1,326.51 | -61.98 | -92.47 | -184.17 |
| Net Margin
| -- | -369.76 | -69.03 | -- | -- |
| Return on equity
| -110.49 | -85.54 | -88.26 | -90.45 | -155.91 |
| Return on Capital
| -108.94 | -84.42 | -- | -88.83 | -153.52 |
| Return on Assets
| -56.19 | -49.16 | -32.16 | -45.05 | -71.89 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.01 | 0.02 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
-88.83
|
-153.52
|
-84.46
|
-65.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-88.26
Lower than Peers by 48.74
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-88.26
|
-90.45
|
-155.91
|
-85.10
|
-66.05
|
|
Peer Median
|
-39.52
|
--
|
--
|
--
|
--
|
ROA
-32.16
Lower than Peers by 1.02
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-32.16
|
-45.05
|
-71.89
|
-51.64
|
-50.88
|
|
Peer Median
|
-31.14
|
--
|
--
|
--
|
--
|
EBIT Margin
-61.98
Lower than Peers by 1.96
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-61.98
|
-92.47
|
-184.17
|
-219.85
|
-744.22
|
|
Peer Median
|
-60.02
|
--
|
--
|
--
|
--
|
Net Margin
-69.03
Lower than Peers by 0.16
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-69.03
|
-103.57
|
-200.27
|
-238.52
|
-673.88
|
|
Peer Median
|
-68.87
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
61.04
Higher than Peers by 6.04
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
61.04
|
0.46
|
0.68
|
2.28
|
6.49
|
|
Peer Median
|
55.00
|
--
|
--
|
--
|
--
|
EBIT Growth
-2.07
Lower than Peers by 0.60
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-2.07
|
26.79
|
-40.79
|
3.24
|
-3.45
|
|
Peer Median
|
-1.47
|
--
|
--
|
--
|
--
|
Net Profit Growth
-0.77
Higher than Peers by 5.28
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-0.77
|
24.58
|
-41.11
|
-1.97
|
-166.32
|
|
Peer Median
|
-6.05
|
--
|
--
|
--
|
--
|
EPS Growth
6.43
Lower than Peers by 6.94
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
6.43
|
0.31
|
-0.36
|
0.03
|
-1.38
|
|
Peer Median
|
13.36
|
--
|
--
|
--
|
--
|
Book Value Growth
-36.48
Lower than Peers by 28.28
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-36.48
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-8.20
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
0.01
|
0.02
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
0.00
|
0.00
|
0.01
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.78
Lower than Peers by 3.02
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
2.78
|
4.41
|
3.24
|
5.58
|
8.90
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
2.57
Lower than Peers by 3.08
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
2.57
|
4.16
|
3.08
|
5.43
|
8.83
|
|
Peer Median
|
5.65
|
--
|
--
|
--
|
--
|
Interest Coverage
-9.54
Lower than Peers by 7.46
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-9.54
|
-8.52
|
-11.63
|
-12.25
|
-33.82
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
13.93
Lower than Peers by 4.94
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
13.93
|
13.74
|
14.23
|
19.20
|
26.33
|
|
Peer Median
|
18.87
|
--
|
--
|
--
|
--
|
Asset Turnover
0.47
Higher than Peers by 0.40
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
0.47
|
0.43
|
0.36
|
0.22
|
0.07
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
42.92
|
46.85
|
49.75
|
56.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
416.87
|
373.84
|
226.58
|
259.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
246.18
|
235.15
|
190.09
|
901.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
213.61
|
185.54
|
86.24
|
-586.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
-36.42
|
-13.23
|
-14.74
|
-9.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
86.69
Higher than Peers by 82.38
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
86.69
|
26.51
|
20.96
|
16.03
|
6.20
|
|
Peer Median
|
4.31
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-12.65
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
-12.65
|
-38.90
|
-13.15
|
-14.53
|
-7.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
7,974
Higher than Peers by 7,836
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Rhythm Pharmaceuticals (RYTM)
|
7,974
|
--
|
--
|
--
|
--
|
|
Peer Median
|
138
|
--
|
--
|
--
|
--
|